OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin–ferroptosis axis
Zhili Li, Claude Caron de Fromentel, Woojun Kim, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 10

Showing 10 citing articles:

S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism
Min Yang, Weiwei Cui, Xiaoting Lv, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Exploring the Molecular Interactions Between Ferroptosis and the Wnt/β-Catenin Signaling Pathway: Implications for Cancer and Disease Therapy
Hui Jia, Che Bian, Yi Chang
Critical Reviews in Oncology/Hematology (2025), pp. 104674-104674
Closed Access

Babaodan inhibits cell proliferation and metastasis and enhances anti-tumor effects of camrelizumab by inhibiting M2 phenotype macrophages in hepatocellular carcinoma
Caiyan Liu, Xiaowei Lin, Manru Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118540-118540
Closed Access | Times Cited: 2

DDX5 deficiency drives non-canonical NF-κB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression
Zhili Li, Woojun Kim, Sagar M. Utturkar, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 2

Mechanisms of sorafenib resistance in hepatocellular carcinoma
Yuanjing Liang
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102434-102434
Closed Access | Times Cited: 1

Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma
Yiliang Wang, Nu Li, Letian Qu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Targeting STK26 and ATG4B: miR-22-3p as a modulator of autophagy and tumor progression in HCC
Kai Li, Yaping Bai, Jingtong Wang, et al.
Translational Oncology (2024) Vol. 51, pp. 102214-102214
Open Access | Times Cited: 1

The regulatory role of mitotic catastrophe in hepatocellular carcinoma drug resistance mechanisms and its therapeutic potential
Jianwang Li, Xiaozhen Cheng, Denggao Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117598-117598
Open Access

Page 1

Scroll to top